NeuroBo Pharmaceuticals Inc. (NRBO) Social Stream
NeuroBo Pharmaceuticals Inc (NRBO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NRBO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 31, 2021
The Trend in the Analyst Price Target
NRBO's average price target has moved down $9 over the prior 33 weeks.
Over the past 170 days, NRBO's average upside potential has been 363.02%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NRBO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NRBO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, NeuroBo Pharmaceuticals Inc's number of analysts covering the stock is greater than nearly none of them.
- To contextualize these metrics, consider that out of all US stocks, NeuroBo Pharmaceuticals Inc's variance in analysts' estimates is lower than almost 100% of them.
- In the context of Healthcare stocks, NeuroBo Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 99.32% of them.
- In the context of Healthcare stocks, NeuroBo Pharmaceuticals Inc's average analyst price target is higher than 25.89% of them.
In the Pharmaceutical Products industry, NBY, NBSE, and MTCR are the three stocks most similar to NeuroBo Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for NRBO? Use POWR Ratings for clearer insight into price direction.